Edwards Lifesciences Cash and Equivalents USD Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 108.25  0.27  0.25%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Cash and Equivalents USD of Edwards Lifesciences Corporation with missing and latest data points interpolated. Cash and Equivalents in USD, converted by [FXUSD].
Cash and Equivalents USD  10 Years Trend  
Increasing
Slightly volatile
 Cash and Equivalents USD 
      Timeline 

Edwards Lifesciences Cash and Equivalents USD Over Time

2015-12-31  718,400,000 
2016-12-31  930,100,000 
2017-12-31  867,631,579 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  434,235,965
Geometric Mean  329,874,702
Coefficient Of Variation  67.32
Mean Deviation  238,831,287
Median  396,100,000
Standard Deviation  292,345,956
Range  882,400,000
R Value  0.92
R Squared  0.85
Significance  0.00001776
Slope  74,905,410

Currently Trending

S   
 NYQ 
Purchased over 400 shares of
few hours ago ago
Traded for 7.12
GM   
 NYQ 
Purchased over 60 shares of
few hours ago ago
Traded for 45.88
MSFT   
 NMS 
Purchased over 30 shares of
few hours ago ago
Traded for 77.49